(Q47179053)

11 January 2018

title

Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health (English)

1 reference

11 January 2018

author

Carel le Roux

series ordinal

2

1 reference

11 January 2018

author name string

Alexander D Miras

series ordinal

1

1 reference

11 January 2018

publication date

3 February 2014

1 reference

11 January 2018

The Lancet: Diabetes & Endocrinology

published in

1 reference

11 January 2018

volume

2

1 reference

11 January 2018

issue

2

1 reference

11 January 2018

page(s)

141-151

1 reference

11 January 2018

Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long-term weight-loss maintenance: a meta-analysis of US studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long-term persistence of hormonal adaptations to weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Changes in energy expenditure resulting from altered body weight

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Caloric deprivation increases responsivity of attention and reward brain regions to intake, anticipated intake, and images of palatable foods

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The effects of prolonged caloric restriction leading to weight-loss on food hedonics and reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

A self-regulation program for maintenance of weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Diets with high or low protein content and glycemic index for weight-loss maintenance.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Association of an intensive lifestyle intervention with remission of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Lifestyle change and mobility in obese adults with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery versus conventional medical therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery and long-term cardiovascular events.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Perioperative safety in the longitudinal assessment of bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Nutritional deficiencies after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Systematic review of medium-term weight loss after bariatric operations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Systematic review of sleeve gastrectomy as staging and primary bariatric procedure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Surgical treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Revisional bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long-term results of laparoscopic sleeve gastrectomy for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

How do we define cure of diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

IDF's view of bariatric surgery in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery: an IDF statement for obese Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

All bariatric surgeries are not created equal: insights from mechanistic comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of bariatric surgery on glucose homeostasis and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The effect of gastrointestinal surgery on insulin resistance and insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Improvement in ß-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The Role of β-Cell Function and Insulin Sensitivity in the Remission of Type 2 Diabetes after Gastric Bypass Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Gastric bypass and banding equally improve insulin sensitivity and β cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Restoration of Euglycemia and Normal Acute Insulin Response to Glucose in Obese Subjects With Type 2 Diabetes Following Bariatric Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986-2006 in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Changes in renal function following Roux-en-Y gastric bypass: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Predicting the development of diabetic nephropathy and its progression

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Renal cytokines improve early after bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Acute kidney injury after gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The effect of restrictive bariatric surgery on urinary stone risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery and diabetic retinopathy: a pilot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The Neurological Complications of Nutritional Deficiency following Bariatric Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of bariatric surgery on cardiovascular function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery and cardiovascular outcomes: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Obesity and reproductive disorders in women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The adverse effects of obesity on conception and implantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Maternal obesity: pregnancy complications, gestational weight gain and nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Sex hormone changes in morbidly obese patients after vertical banded gastroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Partial recovery of luteal function after bariatric surgery in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Contraceptive treatment after biliopancreatic diversion needs consensus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effects of gastric bypass surgery on female reproductive function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Influence of weight reduction by sibutramine on female sexual function.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Impact of Bariatric Surgery on Body Image Perception and Sexuality in Morbidly Obese Patients and their Partners

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Surgical management of metabolic dysfunction in PCOS.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Pregnancy and fertility following bariatric surgery: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Reproductive outcome after bariatric surgery: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

Dramatic reduction in sperm parameters following bariatric surgery: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970158-X

7 January 2021

10.1016/S2213-8587(13)70158-X

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

24622718

1 reference

11 January 2018